Leading Experts in QT Interval Prolongation Experts (US)

Bernard Chaitman, Professor and Director of Cardiovascular Research, SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINEBernard Chaitman

Professor and Director of Cardiovascular Research
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Bernard Chaitman, MD, is Professor of Internal Medicine and Director of Cardiovascular Research at the St. Louis University School of Medicine in Missouri. He is also the Director of the Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal...

Eric Gruff, Principal, E4 ConsultingEric Gruff

Principal
E4 Consulting

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Eric Gruff, PhD, MBA, BS, is the Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has 19 years of experience in the pharmaceutical and biotech sector, including...

William Haynes

Director of Clinical Pharmacology
THE UNIVERSITY OF IOWA

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

William Haynes, MD, is Professor of Medicine and Director of Clinical Pharmacology at the University of Iowa. Dr. Haynes has expertise in cardiovascular risk factors including diabetes, hypertension, hyperlipidemia, obesity, and atherosclerosis. He has...

Rami Kaminski

Founder and Director
Institute for Integrative Psychiatry

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Rami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between...

Leo Pavliv

Senior Vice President, Operations
CUMBERLAND PHARMACEUTICALS, INC.

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Leo Pavliv, RPh, MBA, is a Senior Vice President of Operations at Cumberland Pharmaceuticals in Tennessee. His job responsibilities include directing overall drug development activities for numerous products, regulatory affairs, product development, clinical...

Evan Siegel

Adjunct Professor
THE UNIVERSITY OF QUEENSLAND

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Evan Siegel, M Phil, Ph D, is the President and Chief Executive Officer of Ground Zero Pharmaceuticals, a regulatory affairs and product development consulting firm in California, since June 1999. Dr. Siegel is also an Adjunct Professor at the University...

Daniel Wynn, Director, Clinical Research, CONSULTANTS IN NEUROLOGY LTDDaniel Wynn

Director, Clinical Research
CONSULTANTS IN NEUROLOGY LTD

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Daniel Wynn, MD, FACN, FAASM, is the Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 140 clinical trials in...

Page : 11 to 7 of 7

Leading institutions connect with members of the Healthcare councils through GLG